What is BNB Plus?
BNB Plus operates at the intersection of digital asset management and biotechnology. The company is actively involved in managing treasury operations within the BNB ecosystem through sophisticated staking, decentralized finance (DeFi) strategies, and yield optimization techniques. Concurrently, BNB Plus is making strides in life sciences research and development, with a particular emphasis on nucleic acid technologies for advanced biomedical and diagnostic applications. This dual focus allows the company to pioneer innovative solutions by merging financial technology with cutting-edge biotech.
How much funding has BNB Plus raised?
BNB Plus has raised a total of $6.6M across 2 funding rounds:
Debt
$4.1M
Private Equity
$2.5M
Debt (2026): $4.1M with participation from Silvermine Capital
Private Equity (2026): $2.5M, investors not publicly disclosed
Key Investors in BNB Plus
Silvermine Capital
Silvermine Capital Advisors specializes in venture capital, cryptocurrency investments, and special situations, aiming to provide innovative financial solutions. They focus on strategic investment opportunities for a diverse range of clients.
What's next for BNB Plus?
The substantial enterprise-level capital infusion positions BNB Plus for accelerated growth and expanded operational capabilities. The strategic investment signals confidence from backers in the company's diversified business model, encompassing both digital asset management and biotechnology innovation. This backing is expected to fuel further research and development in nucleic acid technologies and enhance its DeFi and staking operations within the BNB ecosystem. BNB Plus is poised to leverage this financing to solidify its market position and explore new avenues for expansion in both its financial and life sciences ventures.
See full BNB Plus company page
